Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Retatrutide for Type 2 Diabetes
Recruiting1 awardPhase 3
Billings, Montana
"This trial will test if retatrutide is better than a placebo for treating Type 2 Diabetes in people with kidney problems. Participants will be those who have not been able to control their blood sugar
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.